Genmab — Januar 2024
-
Atså i klinikken og ikke præ-klinik. Eller er jeg helt ved siden af skiven? 30 mia burde da kunne understøtte et eller 2 fase 3 programmer….
-
Vi kan jo håbe lidt på, at Jan nu kan lukke lidt mere op for posen - nu er voldgiftsbåndet væk.Må indrømme, at jeg håber lidt på, at kvartalsregnskabet følges op med en lidt håndfast strategi.
-
Synes Jan sagde på ASH eller JP Morgan, at de i højere grad retter fokus mod development og holder lidt igen på research. Sikkert klogt med patentudløb på daratumumab for øje. Drømmer stadig om at GEN1042 kan noget særligt, men blev lidt nervøs da vi intet hørte i slutningen af 2023.
-
NJ Stock: What to Consider Before Its Next Dividend Hike https://www.proinvestor.com/investornyt/1108802/jnj-stock-what-to-consider-before-its-next-dividend-hike
-
Perseus video https://www.youtube.com/watch?v=mpiSaMj0kFY
-
-
All About TALVEY (talquetamab) - video https://www.youtube.com/watch?v=sUQnK-a4TvY
-
'epcoritamabe' was also in approved in Brazil last dec
https://jornaldr1.com.br/anvisa-aprova-primeiro-anticorpo-biespecifico-para-tratar-tipo-agressivo-de-cancer-no-sangue/ -
Alligator Bioscience Announces Positive Mitazalimab OPTIMIZE-1 Phase 2 Results Meeting Primary Endpoint and Demonstrating Clinically Relevant Survival Benefits in 1st Line Pancreatic Cancer – Alligator Bioscience
Top-line readout demonstrates Objective Response Rate of 40.4%, meeting primary endpoint and confirming the benefit of mitazalimab in combin ...
(alligatorbioscience.se)
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind